Maag Peter's Form 4 filing
CareDx, Inc. (CDNA) · filed Jan 6, 2022
- Accession no.
- 0001217234-22-000012
- Filed
- Jan 6, 2022
- Trade date
- Jan 5, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $444.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maag PeterCIK 0001613855 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Common Stock | MOption exerciseAcquired | +925 | $6.31 | +$5,836.75 | 342,681 | Direct | |
| Jan 5, 2022 | Common Stock | MOption exerciseAcquired | +3,340 | $24.35 | +$81,329 | 346,021 | Direct | |
| Jan 5, 2022 | Common Stock | MOption exerciseAcquired | +5,735 | $27.17 | +$155,819.95 | 351,756 | Direct | |
| Jan 5, 2022 | Common Stock | SSaleDisposed | −8,146 | $44.29F2 | −$360,786.34 | 343,610 | Direct | |
| Jan 5, 2022 | Common Stock | SSaleDisposed | −1,854 | $45.13F3 | −$83,671.02 | 341,756 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Common Stock | MOption exerciseDisposed | −925 | $0.00 | $0 | 6,165 | Direct | |
| Jan 5, 2022 | Common Stock | MOption exerciseDisposed | −3,340 | $0.00 | $0 | 41,667 | Direct | |
| Jan 5, 2022 | Common Stock | MOption exerciseDisposed | −5,735 | $0.00 | $0 | 61,164 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.80, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45 to $45.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.